Hims & Hers stock surges as weight loss drugs help drive earnings
The company's CEO said its weight loss offerings could generate $100 million in revenue in 2025
Stay updated with breaking news from Hims Amp Hers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company's CEO said its weight loss offerings could generate $100 million in revenue in 2025
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.
Starting with the larger brand of the two the company operates (Hims), Heart Health by Hims is the company’s first answer to one of the most devastating healthcare problems globally, cardiovascular disease (CVD)..
Explore the ever-changing digital health market, from startups to established companies restructuring their strategies.